Comprehensive Market Analysis on Consumer Genomics Market projected to reach USD 10.0 Billion by 2030 | CAGR of 22.2% | Forecast period 2022-2030, published by MarketDigits

Consumer Genomics Market Scope:
Market size value in 2022 - USD 2.0 Billion
Market size value in 2030 - USD 10.0 Billion
CAGR (2023-2030) - 22.2%
Forecast Period - 2022-2030
Segments Covered - Type, Technology, Application and Region.
Geographies Covered - North America, Europe, Asia Pacific, and Row
Sample of Companies Covered - Myriad Genetics. Inc, Positive Biosciences Limited, SomaLogic Operating Co., Inc., Diagnomics, Inc., DNA N U Ltd, Gene by Gene, Ltd.

Download Sample Pages-https://www.marketdigits.com/request/sample/4534

Browse in-depth TOC on Consumer Genomics Market
178-Tables
95-Figures
340-Pages

North America dominates the market for Consumer Genomics.
In North America, the consumer genomics market has seen growth, driven by factors such as increasing consumer awareness, a high prevalence of lifestyle-related diseases, and a proactive approach toward personalized healthcare. The region boasts a well-established healthcare infrastructure, contributing to the widespread adoption of consumer genomics services. Moreover, strategic collaborations between genetic testing companies and healthcare providers, coupled with favorable regulatory frameworks, have propelled market expansion.
The Asia Pacific region presents a dynamic increase in the consumer genomics market. Factors such as a large and diverse population, rising disposable incomes, and a growing awareness of the benefits of genetic testing contribute to the market's expansion. While the market is still emerging, increasing healthcare infrastructure development and a surge in lifestyle-related diseases in countries like China and India create huge opportunities for consumer genomics companies to tap into this vast and untapped market.

Ask for Discount- https://www.marketdigits.com/request/discount/4534

Top Key Players Covered in The Consumer Genomics Market Report-
23andMe, Inc., Amgen Inc., Ancestry, Color Health, Inc., Diagnomics, Inc., DNA N U Ltd, Gene by Gene, Ltd, GenomeWeb, Helix, Inc., Illumina, Inc, Mapmygenome, Metabolon, Inc., Myriad Genetics, Inc, MyHeritage, Positive Biosciences Limited, SomaLogic Operating Co., Inc., Toolbox Genomics, VERITAS and Others.

For More Information - Inquire Now!
https://www.marketdigits.com/request/enquiry-before-buying/4534

Recent Developments-
In May 2023, Grifols, the global healthcare company, announced the launch of its AlphaID AT Home Genetic Health Risk Service. The first-ever free, direct-to-consumer program in the United States designed to assess the genetic risk of alpha1-antitrypsin deficiency.

https://industrytoday.co.uk/market-research-industry-today/emerging-trends-and-innovations-for-the-consumer-genomics-market-projected-to-reach-usd-100-billion-by-2030

MarketDigits
Email: sales@marketdigits.com

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

This release was published on openPR.